Gabapentin Capsule
Product Images NDC 76420-617

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 76420-617). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gaba-fig-1-jpg.jpg (Gaba Fig 1 Jpg)

A line graph showing mean pain scores over 8 weeks comparing placebo and Gabapentin at 3600 mg/day. The x-axis represents weeks with a baseline and indicates a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores ranging from 0 to 10. The graph illustrates a decrease in pain scores over time for Gabapentin while placebo remains relatively stable.*

FDA Label Image

Gaba-fig-2-jpg.jpg (Gaba Fig 2 Jpg)

Line graph depicting mean pain scores over a 7-week period comparing placebo and gabapentin at doses of 1800 mg/day and 2400 mg/day. The x-axis shows weeks from baseline to week 7, and the y-axis shows mean pain score. The graph distinguishes a 3-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Gaba-fig-3-jpg.jpg (Gaba Fig 3 Jpg)

A bar graph titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and gabapentin (GBP) doses in two studies. Study 1 shows PBO at 12% and GBP 3600 mg at 29%. Study 2 shows PBO at 14%, GBP 1800 mg at 32%, and GBP 2400 mg at 34%. Statistical significance is indicated with p-values below 0.01 or 0.001.*

FDA Label Image

Gaba-fig-4-jpg.jpg (Gaba Fig 4 Jpg)

A scatter plot chart showing difference percentage versus daily dose in milligrams (mg). The chart compares data from three studies labeled as Study a, Study b, and Study c, indicated by different shaded squares. The x-axis represents daily doses ranging approximately from 600 to 1800 mg, and the y-axis shows percentage differences from about 2% to 22%.*

FDA Label Image

Gaba-structure.jpg (Gaba Structure)

Chemical structure of gabapentin, showing a cyclohexane ring with an amino (CH2NH2) and a carboxymethyl (CH2CO2H) side group attached.*

FDA Label Image

Gabapentin-formula-jpg.jpg (Gabapentin Formula Jpg)

A mathematical formula representing creatinine clearance (CLCr), which includes variables such as age (years), weight (kg), serum creatinine (mg/dL), and an adjustment factor for female patients. The formula is shown in a fraction format with specific coefficients.*

FDA Label Image

Gabapentin-label (Gabapentin Label)

Packaging labels for Gabapentin Capsules USP 300mg by Enovachem Pharmaceuticals, manufactured for Granules Pharmaceuticals, Inc. Labels include various package sizes: 30, 60, 90, 100, 120, and 240 capsules. The label features barcodes, QR codes, and storage instructions for this oral prescription drug.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.